BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 28.20
+5.10 (22.08%)
At close: Mar 12, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 135.09 million as of March 12, 2026. Its market cap has decreased by -35.48% in one year.
Market Cap
135.09M
Enterprise Value
61.27M
Revenue
1.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.20
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 135.09M, a decrease of -35.03%. That is a compound annual growth rate of -32.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 135.09M | -5.33% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 910.45M |
| Basilea Pharmaceutica AG | 649.00M |
| Newron Pharmaceuticals | 366.19M |
| Santhera Pharmaceuticals Holding AG | 213.08M |
| Molecular Partners AG | 145.86M |
| Xlife Sciences AG | 127.46M |
| EvoNext Holdings | 6.27M |
| Addex Therapeutics | 5.25M |